Understanding the so-called obesity ‘wonder drugs’
Over the holiday break Exponential View republished a piece by Azeen Azhar it had run earlier in the year on GLP-1 drugs. (In other words, drugs like Ozempic.) First time around, I’d noticed the headline, but not had time to get into the detail. But seeing it during the holiday meant I was able to give it more consideration. The Exponential View headline story is this: I reckon that they will…














